VA Office of Research and Development
PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use nightly surveys to optimize the intervention's effectiveness for smoking cessation among Veteran smokers with chronic pain.
Veterans with chronic pain represent an important population in which to focus smoking cessation efforts. Smoking cessation among patients with chronic medical illnesses substantially decreases morbidity and mortality; yet, many patients (\>50%) with chronic pain continue to smoke. This study aims to: 1. Determine whether the existing integrated pain and smoking cessation (PASS intervention) augmented with nightly surveys (PASS2) is superior to treatment as usual (e.g., referral to standard VA smoking cessation clinic) enhanced with pharmacotherapy tele-consult (E-TAU) at 4 months and 10 mon…
Inclusion Criteria: * being an enrolled Veteran at VACHS * current tobacco use * willingness to make a quit attempt * significant chronic pain defined as \>/=4 on the pain intensity portion of the Brief Pain Inventory (BPI) for more than 90 days Exclusion Criteria: * active diagnosis of dementia or psychosis in medical record * severely impaired hearing or speech * lack of telephone access * enrollment in concurrent research study that might affect main outcomes of this study * terminal illness * non-English speaking * pregnancy * provider advising against exercise * planned surgeries * cli…
An intervention that includes a proactive telehealth intervention combining evidence-based smoking cessation counseling augmented with behavioral approaches for coping with pain, and nightly surveys to report smoking status, pain, and pedometer-measured step counts, which the clinician will use to provide individualized feedback.
Referral to the local smoking cessation VA clinic.
Arctuva estimate
Verify or correct the compensation shown for this listing.